EGFR mutation profile in Australian patients with non-small cell lung cancer
Abstract
No abstract availableFunding Information
- Roche
This publication has 9 references indexed in Scilit:
- Prevalence of the EGFR T790M and other resistance mutations in the Australian population and histopathological correlation in a small subset of casesPathology, 2020
- Correlation between molecular analysis, diagnosis according to the 2015 WHO classification of unresected lung tumours and TTF1 expression in small biopsies and cytology specimens from 344 non-small cell lung carcinoma patientsPathology, 2017
- KRAS mutation testing of tumours in adults with metastatic colorectal cancer: a systematic review and cost-effectiveness analysisHealth Technology Assessment, 2014
- High proportion of rare and compound epidermal growth factor receptor mutations in an Australian population of non‐squamous non‐small‐cell lung cancerInternal Medicine Journal, 2014
- Comprehensive molecular profiling of lung adenocarcinomaNature, 2014
- Outcomes of an Australian testing programme for epidermal growth factor receptor mutations in non‐small cell lung cancerInternal Medicine Journal, 2014
- Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencingBMC Medical Genomics, 2014
- Socioeconomic status and smoking: a reviewAnnals of the New York Academy of Sciences, 2011
- Why we need a population-based approach to clinical indicators for cancer: a case study using microscopic confirmation of lung cancer in QueenslandInternal Medicine Journal, 2006